HOME >> BIOLOGY >> NEWS
Interferons effective against smallpox

BALTIMORE March 11, 2003 Proteins produced by the immune system, known as interferons, may be an effective treatment for smallpox, say researchers today at the American Society for Microbiologys Biodefense Research Meeting.

Certain cytokines, particularly interferons, are well known for their antiviral effects in various virus infections, says Ge Liu of Advanced Biosystems, Inc. in Manassas, Virginia, a lead researcher in the study, in collaboration with scientists from the Southern Research Institute in Frederick, Maryland, and George Mason University.

The researchers tested the ability of a number of interferons and interleukins, administered intranasally, to protect mice from a lethal infection with vaccinia virus, a close relative to the smallpox virus that is often used in mice to test potential smallpox treatments. Mice treated with interferons alpha and gamma had survival rates over 95 percent, compared to control groups in which no mice survived.

Intranasal administration of interferon alpha and interferon gamma provides nearly full protection against respiratory vaccinia virus infection in mice, says Liu. Therefore, our results have implications in the utilization of interferon as a prophylactic tool in a scenario of aerosol orthopoxvirus infection.

The American Society for Microbiology (ASM) is the largest single life science society, composed of over 42,000 scientists, teachers, physicians, and health professionals. Its mission is to promote research and training in the microbiological sciences and to assist communication between scientists, policymakers, and the public to improve health, economic well being, and the environment.


'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
11-Mar-2003


Page: 1

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. Endurance exercise found to be equally effective as diuretics in improving cardiac health
3. Purdue yeast makes ethanol from agricultural waste more effectively
4. Scientists learn how adjuvant makes vaccines effective
5. Super-effective jumping gene created
6. Drug combo effective in advanced breast cancer
7. Data show investigational antibiotic safe, effective in preventing travelers diarrhea
8. Mexican farmers effectively cultivate phenotypic diversity in maize
9. Newer drugs more effective at curing strep throat than penicillin
10. Researchers show chronic sinusitis is immune disorder; antifungal medicine effective treatment
11. Ribozyme package effective against hepatitis B virus

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Interferons effective against smallpox

(Date:8/24/2015)... 24, 2015 The consulting company Frost ... biometrics manufacturer DERMALOG and its customized solutions and products for ... Company of the Year Award". DERMALOG is particularly successful with ...   -Cross reference: Picture is available at AP ... On Thursday evening, in South Africa,s ...
(Date:8/19/2015)... N.Y. , Aug. 19, 2015  VOXX ... that it has entered into a Definitive Agreement ... property, of iris authentication market leader EyeLock through ... VOXX will have a controlling interest in the ... subject to completion of due diligence.  Expanding on ...
(Date:8/12/2015)... Florida , August 12, 2015 ... pace of mobile payment innovation and advanced biometrics technology ... replace the way consumers rely on using their credit ... with reinventing the future for payment services led by ... NXTD ), :  Google, Inc. (NASDAQ: GOOG ...
Breaking Biology News(10 mins):Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6
(Date:9/2/2015)... Israel , September 2, 2015 ... the intent of the National Institute of Allergy and Infectious ... (NIH) within the Department of Health and Human Services (HHS), ... in the United States in the ... universal flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, ...
(Date:9/2/2015)... ... September 02, 2015 , ... Advancing ... high-risk surgeries. From vital sign monitoring in ICU to 3D skull printing analysis ... to make real-time clinical decisions with simultaneous access to high precision medical images ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... of their entire waste to energy process and continue to contribute to the ... Upgrade , Temarry’s Waste to Energy process has been operating at their Mexico ...
(Date:9/2/2015)... ... 2015 , ... Genedata, a leading provider of advanced software ... ® version 13.0 at ELRIG Drug Discovery 2015. This latest version of the ... new capabilities. Screener now supports High Throughput Flow Cytometry (HT-Flow) and Drug Metabolism ...
Breaking Biology Technology:BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4
Cached News: